 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Svaks Biotech India Pvt Ltd (SBIPL), the Promoter of Lasa Supergenerics Ltd continues to dump its shares through open market selling. The promoter entity sold 1,873 equity shares on Feb 15, 2018 at a price of Rs. 142 which reduced its stake from 106936 equity shares (0.47%)	to 105063 shares (0.46%).
It again sold 6556 equity shares on Feb 16, 2018 at a price of Rs. 135 through open market selling which reduced its stake further from 105063 shares (0.46%) to 98507 shares (0.43%).
Svaks Biotech India Pvt Ltd was holding 3,37,774 equity shares or 1.48% in Lasa as per the shareholding pattern on December 31, 2017.
Shares of Lasa Supergenerics Ltd was last trading in BSE at Rs.122.8 as compared to the previous close of Rs. 129.25. The total number of shares traded during the day was 82077 in over 469 trades.
The stock hit an intraday high of Rs. 128 and intraday low of 122.8. The net turnover during the day was Rs. 10117546.